Kidney Cancer

As pioneers in the diagnosis and treatment of kidney cancer, our team of experts treats people who travel from all over the world to seek our care. We use sophisticated imaging tests, including specialized MRI and CT scans, and our surgeons are leaders in robotic-assisted and organ-sparing surgical techniques. What’s more, we are one of the only medical centers in New York to offer interleukin 2, a medication that is the only treatment known to lead to remission in kidney cancer that has spread.

Clinical Trials and Research Studies

Phase 5

A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (U03): Substudy 03B

Learn More

Phase 5

A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants with RCC (U03): Substudy 03A

Learn More

Phase 1

An Open-label Multicenter Dose Escalation Phase 1b Study to Assess the Safety and Pharmacokinetics of Subcutaneous Delivery of Amivantamab a Human Bispecific EGFR and cMet Antibody for the Treatment of Subjects with Advanced Non-Small Cell Lung Cancer

Learn More

Phase 5

First-in-human open-label dose-escalation trial with expansion cohorts to evaluate safety of GEN1046 in subjects with malignant solid tumors

Learn More